Abstract:Abstract Renal cell carcinoma (RCC) is the most lethal genitourinary cancer. Cigarette smoking, hypertension and obesity are the major risk factors for RCC; however, much of the etiology of this disease remains to be elucidated. Genomic DNA hypomethylation is a hallmark of most cancer genomes, promoting genomic instability and cell transformation. In the present study, we sought to determine whether global DNA methylation in peripheral blood is associated with risk of RCC. A case control study consisting of 889 RCC cases and an equal number of age, gender, and ethnicity-matched controls was conducted. Genomic DNA was isolated from peripheral blood and global DNA methylation was measured as 5-mC% content using an antibody-based immune assay. Logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (CI) for the association between DNA methylation level and the risk of RCC. The median age was 59.29±10.42 for cases and 59.39±10.30 for controls. Over two-thirds (67% in both cases and controls) were males, about half (50.2% in cases and 52.2% in controls) were never smokers, the vast majority (84.8% in both cases and controls) were Caucasian. BMI, physical activity, hypertension and family history of cancer were significantly different between cases and controls. RCC cases are more likely than controls to have high blood pressure level (p = 5.81E-15), higher BMI (p = 0.011), low physical activity (p = 1.48E-20), and a family history of cancer (other than kidney cancer) (p = 5.42E-07). The median methylation level in controls was 3.97, significantly higher than the median level of 3.64 in cases (p<0.001 Wilcoxon rank-sum test). In multivariate logistic regression analysis adjusted by age, gender, ethnicity, smoking status, and hypertension, individuals in the lowest tertile (T1) and middle tertile (T2) of 5-mC% had higher risks of RCC with ORs of 1.42 (95%CI 1.12-1.81) and 1.14 (95% CI 0.89-1.45), respectively, compared to individuals in the highest tertile (T3) of methylation (p for trend 0.004). When stratified by RCC risk factors, associations between hypomethylation and increased RCC risks were stronger among males (OR 1.64, 95%CI 1.21-2.21), younger individuals (OR 1.54, 95%CI 1.10-2.15), never-smokers (OR 1.61, 95%CI 1.14-2.28) and African-Americans (OR 2.75, 95%CI 0.75-10.08). These findings suggest for the first time that global DNA hypomethylation in peripheral blood is independently associated with RCC risk. The results may provide better understanding of the etiology of RCC tumorigenesis and in combination with modifiable risk factors and other potential biomarkers, may help identify high risk individuals for screening and early detection of RCC. This work was supported in part by the National Institutes of Health (grant R01 CA170298) and the Center for Translational and Public Health Genomics, Duncan Family Institute for Cancer Prevention, The University of Texas M D Anderson Cancer Center. Citation Format: Julia Mendoza Perez, Jian Gu, Nizar M. Tannir, Surena Matin, Jose A. Karam, David W. Chang, Luis A. Herrera, Christopher G. Wood, Xifeng Wu. Genomic DNA hypomethylation as an independent risk factor for renal cell carcinoma. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 2953. doi:10.1158/1538-7445.AM2015-2953

Gene-Environment Interaction of Genome-Wide Association Study-Identified Susceptibility Loci and Meat-Cooking Mutagens in the Etiology of Renal Cell Carcinoma

Abstract 836: Gene-environment Interaction of Genome-Wide Association Study-Identified Susceptibility Loci and Meat-Cooking Mutagens in Renal Cell Carcinoma Etiology

A Genetic Variant In Mir-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis Of 15 Case-Control Studies

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer

Predictors of dietary heterocyclic amine intake in three prospective cohorts

Abstract 1262: Established Genetic Variants and Dietary Patterns Jointly Impact Risk of Renal Cell Carcinoma in Non-Hispanic Whites

A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association

Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma

Abstract 2825: Red Meat and Heterocyclic Amine Intake, Metabolic Pathway Genes, and Bladder Cancer Risk

Potential role of gene-environment interactions in ion transport mechanisms in the etiology of renal cell cancer

Dietary meat intake in relation to colorectal adenoma in asymptomatic women

Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk

The role of diet in renal cell carcinoma incidence: an umbrella review of meta-analyses of observational studies

One-carbon Metabolism Pathway Gene Variants and Risk of Clear Cell Renal Cell Carcinoma in a Chinese Population.

Meat consumption and the risk of incident distal colon and rectal adenoma

Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China

Abstract 2953: Genomic DNA Hypomethylation As an Independent Risk Factor for Renal Cell Carcinoma

Micronutrients and Risks of Three Main Urologic Cancers: A Mendelian Randomization Study

Abstract 4349: Identifying Causal Risk Factors of Metabolic Syndrome for Renal Cell Carcinoma. A Mendelian Randomization Approach